Literature DB >> 4911843

Antiviral activity of antiserum specific for an influenza virus neuraminidase.

E D Kilbourne, W G Laver, J L Schulman, R G Webster.   

Abstract

Antiserum specific for influenza A(2) neuraminidase was produced by immunization of rabbits with the purified enzyme which had been isolated by electrophoresis from the proteins of a detergent-disrupted A(0)A(2) influenza virus recombinant [X-7 (F1)]. This recombinant contained hemagglutinin of the A(0) subtype and A(2) neuraminidase. Antiserum to the isolated A(2) neuraminidase did not react in any of four serological tests with A(0) or A(2) subtype viruses that lacked the A(2) enzyme. In contrast, the antiserum inhibited the neuraminidase activity only of wild-type and recombinant viruses containing the A(2) enzyme, regardless of the nature of their hemagglutinin proteins. The antiserum caused hemagglutination-inhibition of some, but not all, viruses bearing the A(2) enzyme, and it reduced the plaque size or plaque number of all viruses tested that contained A(2) neuraminidase. In the chick embryo and in cell culture, low dilutions of antiserum reduced the yield of virus. True neutralization of virus in the chick embryo did not occur. We conclude that an antiserum specific for A(2) neuraminidase influenced the yield and release of virus from influenza virus-infected cells.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4911843      PMCID: PMC375612     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  11 in total

1.  STRUCTURAL STUDIES ON THE PROTEIN SUBUNITS FROM THREE STRAINS OF INFLUENZA VIRUS.

Authors:  W G LAVER
Journal:  J Mol Biol       Date:  1964-07       Impact factor: 5.469

2.  Studies on the neuraminidase of influenza virus. I. Separation and some properties of the enzyme from Asian and PR8 strains.

Authors:  L W MAYRON; B ROBERT; R J WINZLER; M E RAFELSON
Journal:  Arch Biochem Biophys       Date:  1961-03       Impact factor: 4.013

3.  Collocalia mucoid: a substrate for myxovirus neuraminidase.

Authors:  C HOWE; L T LEE; H M ROSE
Journal:  Arch Biochem Biophys       Date:  1961-12       Impact factor: 4.013

4.  Preparation and properties of antibody directed specifically against the neuraminidase of influenza virus.

Authors:  R G Webster; W G Laver
Journal:  J Immunol       Date:  1967-07       Impact factor: 5.422

5.  Functional significance of sialidose during influenza virus multiplication.

Authors:  J T Seto; R Rott
Journal:  Virology       Date:  1966-12       Impact factor: 3.616

6.  Genetic studies of influenza viruses. 3. Production of plaque-type recombinants with A0 and A1 strains.

Authors:  A Sugiura; E D Kilbourne
Journal:  Virology       Date:  1966-05       Impact factor: 3.616

7.  Identification in a recombinant influenza virus of structural proteins derived from both parents.

Authors:  W G Laver; E D Kilbourne
Journal:  Virology       Date:  1966-11       Impact factor: 3.616

8.  Reduction in plaque size and reduction in plaque number as differing indices of influenza virus-antibody reactions.

Authors:  R I Jahiel; E D Kilbourne
Journal:  J Bacteriol       Date:  1966-11       Impact factor: 3.490

9.  Changing viral susceptibility of a human cell line in continuous cultivation. I. Production of infective virus in a variant of the Chang conjunctival cell following infection with swine or N-WS influenza viruses.

Authors:  S C WONG; E D KILBOURNE
Journal:  J Exp Med       Date:  1961-01-01       Impact factor: 14.307

10.  Genetic studies of influenza viruses. I. Viral morphology and growth capacity as exchangeable genetic traits. Rapid in ovo adaptation of early passage Asian strain isolates by combination with PR8.

Authors:  E D KILBOURNE; J S MURPHY
Journal:  J Exp Med       Date:  1960-03-01       Impact factor: 14.307

View more
  107 in total

1.  Characterization of myxovirus sialidase.

Authors:  T Aoyagi; T Komiyama; K Nerome; T Takeuchi; H Umezawa
Journal:  Experientia       Date:  1975-08-15

2.  Biological and protective properties of immune sera directed to the influenza virus neuraminidase.

Authors:  Stefan J Halbherr; Thomas H Ludersdorfer; Meret Ricklin; Samira Locher; Marianne Berger Rentsch; Artur Summerfield; Gert Zimmer
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

3.  Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses.

Authors:  Matthew R Sandbulte; Kim B Westgeest; Jin Gao; Xiyan Xu; Alexander I Klimov; Colin A Russell; David F Burke; Derek J Smith; Ron A M Fouchier; Maryna C Eichelberger
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

Review 4.  Influenza vaccines: from surveillance through production to protection.

Authors:  Pritish K Tosh; Robert M Jacobson; Gregory A Poland
Journal:  Mayo Clin Proc       Date:  2010-01-29       Impact factor: 7.616

5.  Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice.

Authors:  P C Reading; L S Morey; E C Crouch; E M Anders
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

6.  Enhanced growth of seed viruses for H5N1 influenza vaccines.

Authors:  Taisuke Horimoto; Shin Murakami; Yukiko Muramoto; Shinya Yamada; Ken Fujii; Maki Kiso; Kiyoko Iwatsuki-Horimoto; Yoichiro Kino; Yoshihiro Kawaoka
Journal:  Virology       Date:  2007-07-24       Impact factor: 3.616

7.  Inhibition of bovine leukemia virus release by antiviral antibodies.

Authors:  D M Driscoll; M Onuma; C Olson
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

8.  Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults.

Authors:  D C Powers; E D Kilbourne; B E Johansson
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

9.  Subtype cross-reactive, infection-enhancing antibody responses to influenza A viruses.

Authors:  M Tamura; R G Webster; F A Ennis
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

10.  Human sera possess a limited antibody repertoire to influenza neuraminidase antigenic variants selected in vitro.

Authors:  A Natali; P F Panizzi; C Chezzi; J S Oxford
Journal:  J Hyg (Lond)       Date:  1984-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.